# FDA Inspection 1116523 - ReproTech, Ltd. - January 23, 2020

Source: https://www.keypedia.com/records/fda_inspections/reprotech-ltd/0eacaa40-5161-496c-a763-aefd763b3381
Source feed: FDA_Inspections

> FDA Inspection 1116523 for ReproTech, Ltd. on January 23, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116523
- Company Name: ReproTech, Ltd.
- Inspection Date: 2020-01-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1116523 - 2020-01-23](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/d8d66625-1f97-4207-977b-5f927b3fe346)
- [FDA Inspection 1037727 - 2018-01-04](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/73c8a975-a572-45da-92da-592ad75bce1d)
- [FDA Inspection 1037727 - 2018-01-04](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/7bb5f49c-4bc9-47dc-bcba-bb1c904c1a2b)
- [FDA Inspection 952457 - 2015-12-15](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/793908df-4601-4cf8-adb1-57e361d5a729)
- [FDA Inspection 863862 - 2014-01-29](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/4623c23f-c74b-4530-aba3-174810dc5249)

Company: https://www.keypedia.com/companies/reprotech-ltd/3e4f70ef-eb22-4290-a97f-06fe0b9a7b87

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d